
Mobile device to make TB screening simpler
The innovative diagnostic equipment, designed by a team led by Prof.
Pabitra Nath from the physics department, was specifically engineered to serve communities in rural and isolated regions where sophisticated healthcare infrastructure is limited.
A TU spokesperson said the new device stands out as it does not need any chemicals or dyes for TB detection like in conventional techniques, but uses the natural glow (autofluorescence) of TB bacteria for detection of the disease. "The device has a built-in heating system to improve test accuracy and can be operated using a smartphone," he said.
Its affordability at under Rs 25,000 and lightweight design of less than 300 grams makes it highly portable.
These characteristics make it particularly suitable for regions with basic healthcare facilities.
"While LED-FM offers higher sensitivity than conventional optical microscopy, it has several drawbacks. It depends on costly equipment, chemical staining agents like auramine-O, and trained personnel for sample preparation and interpretation," Prof.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Many Retirees Unaware Of No Deposit Car Insurance Based On Their Age
OTTO Insurance
Learn More
Undo
Nath said.
"The device developed by the TU researchers leverages the principle of autofluorescence. The team's key innovation lies in the integration of a heating element within the sensor system. By raising the temperature of the bacterial sample, the system enhances the natural fluorescence signal from mTB cells, enabling trace-level detection without the use of stains or dyes," he added.The research group comprises two scholars, Biprav Chetry and Chunuranjan Dutta, from the Physics Department, alongside JP Saikia and Santanu Goswami from the Molecular Biology and Biotechnology Department, and Abhijit Gogoi representing Labdig Innovations and Systems Pvt.
Ltd. The team already filed a patent for the device (Indian Patent Application No. 202431035472), and their findings were published in the international journal Biosensors and Bioelectronics.
The University's Vice Chancellor, Prof. Shambhu Nath Singh, offered his congratulations and noted that this development could significantly advance TB detection efforts, particularly in rural communities.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
31 minutes ago
- Time of India
Healthcare costs in US to shoot up following Trump tariff on Indian goods: Industry experts
New Delhi: Healthcare costs in the US will increase following the imposition of sweeping 25 per cent tariff plus an unspecified penalty on Indian goods, experts from pharmaceuticals and medical devices industry said on Thursday. President Donald Trump on Wednesday announced the imposition of a 25 per cent tariff on all goods coming from India starting August 1, plus an unspecified penalty for buying Russian crude oil and military equipment. Explore courses from Top Institutes in Please select course: Select a Course Category healthcare Project Management Finance Technology Operations Management Artificial Intelligence Data Science Management PGDM Data Science Product Management Degree Others Healthcare Public Policy Design Thinking Cybersecurity Digital Marketing others CXO Leadership MCA MBA Data Analytics Skills you'll gain: Duration: 11 Months IIM Lucknow CERT-IIML Healthcare Management India Starts on undefined Get Details Profits for Indian pharmaceutical firms may decline and research and development may stagnate. However, for the medical devices sector as long as the gap between duty on China and India is over 15- 20 per cent, there are positive prospects for exports to the US, according to experts. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Top 15 Most Beautiful Women in the World Undo "India isn't just a key supplier of generics to the US. We are a part of the backbone of affordable global healthcare. These duties may interrupt the smooth trade flow, inflate US drug costs, stall treatments, and put even greater pressure on American healthcare budgets," OmniActive Health Technologies Executive Chairman and MD Sanjaya Mariwala said. On the other hand, he said, "Back home, the profits for Indian pharmaceutical firms may decline, and R&D may stagnate, slowing down innovation and stalling new drug clearances." Live Events AiMeD (Association of Indian Medical Device Industry) Forum Coordinator Rajiv Nath said, "Duties impact for Indian medical devices sector has to be seen from relative competitiveness - as long as duty gap between Chinese versus Indian is over 15- 20 per cent, we have positive prospects to export to USA and even put production lines in USA." Currently Indonesia and Vietnam have lower duties by 6 per cent. So for products made there they will possibly enjoy a price competitive advantage over India, he added. Stating that clarity will come after August 12 as then duties on Chinese goods will be clear, Nath said, "They were increased to over 50 per cent but temporarily reduced to 30 per cent. If post-August duties on Chinese medical devices revert to over 50 per cent and on Indian at 25 per cent, the export prospects versus China are in our favour..." He further said, "Suffice to say that whatever is the final duty that is finally announced on medical devices, if it's at least 15-20 per cent lower than applicable duty rates by US onto China then there is a strong opportunity for Indian medical devices to increase their exports to US market, if they are able to absorb the excessive high cost of regulatory approval of USFDA for market entry and find that these costs to export are sustainable over the years." However, he said, the government of India and manufacturers will need to work to improve India's competitiveness "so that we can offset the 6 per cent disadvantage over Indonesian and Vietnam competitors". Grant Thornton Bharat Partner and Tax Controversy Management Leader Manoj Mishra pointed out that the strong language used by President Trump and ongoing investigations into drug imports mean that the risk is not over yet. "Indian pharma companies should stay prepared for possible changes, especially if sector-specific duties are introduced later. That said, these tariffs are likely to be in place only for a short period, as both countries are expected to fast-track discussions for a Bilateral Trade Agreement. A balanced and stable trade deal will be key to protecting long-term interests of the sector," he noted. Similarly, Choice Broking Equity Research Analyst- Pharma Sector, Maitri Sheth said the US remains heavily reliant on India for its pharmaceutical needs, with about 50 per cent of generic drugs sourced from India. "Given the critical nature of healthcare and already elevated healthcare costs in the US, we view the likelihood of material near-term tariffs on pharma as low," Sheth added. While the headline risk persists, the structural dependence on Indian pharma and the cost sensitivity of the US healthcare system provide a strong case against aggressive tariff action on the sector, Sheth added. Medical Technology Association of India (MTaI) Chairman Pavan Choudary said President Trump's is "troubling and seems economically shortsighted and strategically misguided".


Time of India
34 minutes ago
- Time of India
Hulk Hogan Cause of Death: Here how the WWE Legend died
Hulk Hogan's cause of death has been revealed. WWE legend Hulk Hogan passed away on July 24, 2025, at the age of 71 after suffering a cardiac arrest at his home in South Florida. Medical reports have now revealed his official cause of death and previously undisclosed health conditions, including cancer. The wrestling world is mourning the loss of one of its biggest icons. Hulk Hogan Cause of Death According to records from the Pinellas County Forensic Science Center, Hulk Hogan died from an acute myocardial infarction, commonly known as a heart attack. He was taken to the hospital from his Clearwater mansion but could not be revived. Explore courses from Top Institutes in Please select course: Select a Course Category Technology Design Thinking Cybersecurity Artificial Intelligence Project Management Data Analytics Degree Public Policy Digital Marketing Data Science Others Finance Healthcare Management MBA CXO Leadership others MCA PGDM Product Management healthcare Operations Management Data Science Skills you'll gain: Duration: 12 Weeks MIT xPRO CERT-MIT XPRO Building AI Prod India Starts on undefined Get Details Medical examinations also confirmed that Hogan had atrial fibrillation, a condition that leads to an irregular heart rhythm. In addition, it was revealed that Hogan had been living with chronic lymphocytic leukemia (CLL), a slow-progressing form of cancer that affects white blood cells. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Food to Help You Poop: Prevent and Relieve Constipation by Eating These Foods Undo Hulk Hogan Cancer Battle Kept Private The documents showed that Hogan never publicly disclosed his battle with leukemia. Chronic lymphocytic leukemia is a condition that often affects older adults and may not show symptoms for years. It can lead to infections, fatigue, and bruising. Doctors usually monitor the condition until treatment becomes necessary. Hogan's health had reportedly been declining in recent months. He underwent neck surgery in May and later faced complications. In June, he experienced difficulty walking and used a cane, but family members downplayed the severity of his condition. Live Events Hulk Hogan Family Reactions After His Death Following his passing, Hogan's wife Sky Hogan shared a heartfelt message. She acknowledged that he had been facing health challenges but believed he would recover. She stated that his strong Christian faith brought her peace during this time. Sky wrote, 'He had been dealing with some health issues, but I truly believed he would overcome them. He was a believer in Christ, and I take comfort knowing his soul is at peace.' The family plans to cremate Hogan's body. No public funeral details have been released. Hulk Hogan Daughter Brooke Hogan Shares Emotional Tribute Brooke Hogan, Hulk Hogan's daughter, also shared her memories after his death. Though their relationship had become strained in recent years due to disagreements about his health, Brooke emphasized their deep bond. She said, 'My dad's blood runs through my veins. Our bond has never broken, not even in his final moments.' Brooke added that she felt part of her spirit leave when he passed and named her daughter Molly Gene Olesky to honor her father's last name. What is Chronic Lymphocytic Leukemia? Chronic lymphocytic leukemia is a cancer that starts in bone marrow and produces abnormal white blood cells. These cells cannot effectively fight infection, leading to a weak immune system. People with CLL may go years without symptoms. Treatment options include targeted drugs, immunotherapy, and chemotherapy. It often has a high survival rate, and many live with it as a chronic condition. Risk factors include age, genetics, and exposure to certain chemicals, such as Agent Orange used during the Vietnam War. FAQs What caused Hulk Hogan's death? Hulk Hogan died from a heart attack. Medical records also revealed he had chronic lymphocytic leukemia, which he had not disclosed publicly. bYes, postmortem reports confirmed Hulk Hogan had chronic lymphocytic leukemia, a slow-growing cancer of the white blood cells.


Time of India
an hour ago
- Time of India
Jitendra Malik's education path: This Indian-origin AI expert went from IIT Kanpur to Stanford, then pioneered machine vision at UC Berkeley
Indian-origin AI expert, Jitendra Malik In the bustling town of Mathura, India, a young boy named Jitendra Malik found himself captivated by puzzles, patterns, and the invisible logic of the world. That boy would one day help teach machines to see. His journey from school classrooms in Jabalpur to the elite laboratories of UC Berkeley, has become a roadmap for aspiring students in both India and abroad. But Malik's story is not just one of academic success. It's about how the power of education—when matched with vision and curiosity, can reshape an entire field. IIT Kanpur : Where genius took flight Jitendra Malik's academic odyssey truly took flight when he earned admission into the Indian Institute of Technology (IIT) Kanpur, one of India's premier engineering institutions. By the time he graduated in 1980, he wasn't just another engineer, rather he was the gold medalist, recognised as the best in his class in electrical engineering. IIT Kanpur provided Malik with more than a rigorous education, it gave him exposure to cutting-edge thought and global ambition. It was here that his interest in systems, computation, and intelligence deepened—foreshadowing a future in artificial intelligence. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Kafr Salim: Unsold Sofas Prices May Surprise You (Prices May Surprise You) Sofas | Search Ads Search Now Undo The AI spark ignites at Stanford After IIT, Malik set his sights westward and joined Stanford University for a PhD in Computer Science. He arrived in California in the early 1980s, just as the digital revolution was beginning to take root. At Stanford, Malik immersed himself in the world of computer vision, an emerging field that asked a fundamental question: Can we teach machines to see like humans? He pursued that question with vigor, completing his PhD in 1985 and helping lay the foundations for the next generation of visual computing. Innovation and mentorship at UC Berkeley In 1986, Malik joined the faculty of the University of California, Berkeley, where he remains to this day as the Arthur J. Chick Professor in Electrical Engineering and Computer Sciences. Over nearly four decades, Malik has pioneered breakthroughs in computer vision, graphics, and machine learning. Concepts such as anisotropic diffusion, shape context, normalised cuts, and R-CNN, now cornerstones of image recognition and AI, emerged from his research group. Malik didn't stop at research. He's also mentored over 60 PhD students and postdoctoral fellows, many of whom now teach and lead in top institutions like MIT, Caltech, CMU, and Cornell. His influence has cascaded across generations of AI thinkers. Leading research in the tech frontier In 2018, Malik took on a new role as Research Director at Facebook AI Research (FAIR) in Menlo Park, California. There, he leads a team pushing the boundaries of computer vision, robotics, and machine learning, helping bridge the gap between academic theory and real-world AI systems. His move reflects a larger trend: world-class researchers shaping not just academic thought, but the technology that powers modern life. A legacy etched in citations Jitendra Malik is one of the most cited computer scientists in the world, with over 150,000 citations and multiple prestigious awards, including the IEEE Computer Pioneer Award, the IJCAI Research Excellence Award, and fellowships from IEEE, ACM, and the National Academy of Sciences. But perhaps his greatest legacy lies in his story of how education at IIT Kanpur and Stanford equipped him not just with knowledge, but with the tools to pioneer, to question, and to lead. Jitendra Malik's journey shows that a solid foundation, combined with relentless curiosity, can carry a student from small-town India to the global stage of AI. His path isn't just a personal success story; it's a blueprint for how education can shape not only a career but an entire field. For today's students dreaming of building future technologies, Malik's life offers a powerful reminder: where you begin doesn't limit where you can go, especially when learning leads the way. TOI Education is on WhatsApp now. Follow us here . Ready to navigate global policies? Secure your overseas future. Get expert guidance now!